Patents by Inventor Juan Morote Robles

Juan Morote Robles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROGNOSTIC METHOD
    Publication number: 20160010160
    Abstract: A method for prognosing recurrence of prostate cancer (PCa) in a subject following prostatectomy using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping PCa associated genetic variations comprising use of a DNA microarray. A microarray for use in the described methods.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 14, 2016
    Applicant: PROGENIKA BIOPHARMA, S.A.
    Inventors: Jokin del Amo, Diego Tejedor Hernandez, Antonio Martinez Martinez, Laureano Simon Buela, Juan Morote Robles
  • Prognostic method
    Patent number: 9109257
    Abstract: A method for prognosing recurrence of prostate cancer (PCa) in a subject following prostatectomy using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping PCa associated genetic variations comprising use of a DNA microarray. A microarray for use in the described methods.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: August 18, 2015
    Assignee: Progenika Biopharma, S.A.
    Inventors: Jokin Del Amo, Diego Tejedor Hernández, Antonio Martínez Martínez, Laureano Simón Buela, Juan Morote Robles
  • METHODS AND KITS FOR THE DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20130178393
    Abstract: The invention relates to methods and kits for the diagnosis of prostate cancer (PCa) in a subject, for assessing or monitoring the response to a therapy in a subject having PCa or for monitoring the progression of prostate cancer PCa based on the detection of alteration in the expression levels of at least one gene selected from the group of PC A3, PSMA and PSGR. The invention relates as well to methods for assessing whether a subject has to be subjected to a prostate biopsy, said subject having a serum PSA range within 4-10 ng/mL.
    Type: Application
    Filed: July 14, 2011
    Publication date: July 11, 2013
    Inventors: Andreas Doll, Marina Rigau Resina, Juan Morote Robles, Miguel Abal Posada, Jaume Reventós Puigjaner
  • METHODS AND KITS FOR THE DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20130171653
    Abstract: The present invention relates to the use of PSGR, a member of the G-protein-coupled olfactory receptor family which is over-expressed in prostate cancer tissue, as a marker suitable for an urine-based diagnostic test for prostate cancer which require only typical prostate manipulation and sample acquisition scenarios avoiding invasive tissue collection.
    Type: Application
    Filed: July 14, 2011
    Publication date: July 4, 2013
    Applicant: FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON, FUNDACIÓ PRIVADA
    Inventors: Andreas Doll, Marina Rigau Resina, Miguel Abal Posada, Juan Morote Robles, Jaume Reventós Puigjaner
  • Prognostic method
    Publication number: 20100185429
    Abstract: A method for prognosing recurrence of prostate cancer (PCa) in a subject following prostatectomy using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping PCa associated genetic variations comprising use of a DNA microarray. A microarray for use in the described methods.
    Type: Application
    Filed: July 12, 2007
    Publication date: July 22, 2010
    Inventors: Jokin del Amo, Diego Tejedor Hernandez, Antonio Martínez Martínez, Laureano Simón Buela, Juan Morote Robles